CD4 and neoplasm: Moreover, TGF-β skews CD4+ T cells to Tregs and shifts macrophages and neutrophils to anti-inflammatory phenotypes, which promote tumor growth and metastasis via various mechanisms, such as angiogenesis, lymphangiogenesis, and epithelial-mesenchymal transition (EMT).